Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Phase 2 Randomized, Non-Comparative Study of Ticilimumab or Best Supportive Care Immediately Following First-Line, Platinum-Based Therapy in Patients with STage IIIB (with effusion) IV Non-Small Cell Lung Cancer that has Responded or Remained Stable
Rinehart, John
(PI)
Arnold, Susanne
(CoI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
6/1/06
→
5/31/10
Funding
Pfizer Inc.:
$26,801.00
View all
View less